Barrett's oesophagus: Pathophysiology, diagnosis, and management

Scandinavian Journal of Gastroenterology

Volumn 33, Issue 5, 1998, Pages 449-453

  Van Den Boogert, J ^a   Van Hillegersberg, R ^a   De Bruin, R W F ^a   Tilanus, H W ^a   Siersema, P D ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BARRETT ESOPHAGUS; CLINICAL FEATURE; DYSPLASIA; GASTROESOPHAGEAL REFLUX; LASER SURGERY; MALIGNANT TRANSFORMATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING;

ADENOCARCINOMA; BARRETT ESOPHAGUS; BIOPSY, NEEDLE; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; HUMANS; PROGNOSIS;

EID: 0031807620     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365529850171981     Document Type: Review

References (50)

1. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265:1287-9.
2. Cameron AJ, Lomboy CT, Pera M, Carpenter HA. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology 1995;109:1541-46.
3. Barrett NR. Chronic peptic ulcer of the oesophagus and 'oesophagitis'. Br J Surg 1950;38:175-82.
4. Spechler SJ, Goyal RK. The columnar-lined esophagus, intestinal metaplasie, and Norman Barrett. Gastroenterology 1996;110:614-21.
5. McClave SA, Worth Boyce H Jr, Gottfried MR. Early diagnosis of columnar-lined esophagus: a new endoscopic diagnostic criterion. Gastrointest Endosc 1987;33:413-6.
6. Hameeteman W, Tytgat GNJ, Houthoff HJ, van den Tweel JG. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 1989;96:1249-56.
7. Tytgat GNJ. Does endoscopic surveillance in esophageal columnar metaplasia (Barrett's esophagus) have any real value? Endoscopy 1995;27:19-26.
8. Clark GWB, Ireland AP, DeMeester TR, Dysplasia in Barrett's esophagus: diagnosis, surveillance and treatment. Dig Dis 1996; 14:213-27.
9. Riddell RH. The biopsy diagnosis of gastroesophageal reflux disease, 'carditis,' and Barrett's esophagus, and sequelea of therapy. Am J Surg Pathol 1996;S31-51.
10. Weinstein WM, Ippoliti AF. The diagnosis of Barrett's esophagus: goblets, goblets, goblets. Gastrointest Endosc 1996; 44:91-5.
11. Spechler SJ, Goyal RK. Barrett's esophagus. N End J Med 1986;315:362-71.
12. Monnier P, Fontolliet C, Savary M, Ollyo JB. Barrett's oesophagus or columnar epithelium of the lower oesophagus. Baillieres Clin Gastroenterol 1987;1:769-89.
13. Miwa K, Sahara H, Segawa M, Kinami S, Sato K, Miyazaki I, et al. Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats. Int J Cancer 1996;67:269-74.
14. Attwood SEA, DeMeester TR, Bremner CG, Barlow AP, Hinder RA. Alkaline gastroesophageal reflux: implications in the development of complications in Barrett's columnar-lined lower esophagus. Surgery 1989;106:764-70.
15. Vaezi MF, Singh S, Richter JE. Role of acid and duodenogastric reflux in esophageal mucosal injury: a review of animal and human studies. Gastroenterology 1995;108:1897-907.
16. Savarino V, Mela GS, Zentilin P, Mele MR, Mansi C, Remagnino AC, et al. Time pattern of gastric acidity in Barrett's esophagus. Dig Dis Sci 1996;41:1379-83.
17. Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA. Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology 1990;99:918-22.
18. Winters C Jr, Spurling TJ, Chobanian SJ, Curtis DJ, Esposito RL, Hacker JF, et al. Barrett's esophagus: a prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 1987;92:118-24.
19. Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 1985;313:857-9.
20. Menke-Pluymers MB, Hop WC, Dees J, van Blankenstein M, Tilanus HW. Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus. The Rotterdam Esophageal Tumor Study Group. Cancer 1993;72:1155-8.
21. Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagastric junction. Gastroenterology 1993;104:510-3.
22. Blot WJ, Devesa SS, Fraumeni JF. Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA 1993;270:1320.
23. Clark GWB, Smyrk TC, Burdiles P, Hoeft SF, Peters JH, Kiyabu M, et al. Is Barrett's metaplasia the source of adenocarcinomas of the cardia? Arch Surg 1994;129:609-14.
24. Wright TA, Gray MR, Morris AI, Gilmore IT, Ellis A, Smart HL, et al. Cost effectiveness of detecting Barrett's cancer. Gut 1996;39:574-9.
25. Spechler SJ, Zeroogian JM, Antonioli DA, Wang HH, Goyal RK. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet 1994;344:1533-6.
26. Geisinger KR, Teot LA, Richter JE. A comparative cytopathologic and histologic study of atypia, dysplasia, and adenocarcinoma in Barrett's esophagus. Cancer 1991;69:8-16.
27. Haggitt RC. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol 1994;25:982-93.
28. Reid BJ, Haggitt RC, Rubin CE, Roth G, Surawicz CM, Van Belle G, et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol 1988;19:166-78.
29. Menke-Pluymers MBE, Mulder AH, Hop WC, van Blankenstein M, Tilanus HW. Dysplasia and aneuploidy as markers of malignant degeneration in Barren's oesophagus. The Rotterdam Oesophageal Tumour Study Group. Gut 1994;35:1348-51.
30. Krishnadath KK, Tilanus HW, van Blankenstein M, Bosman FT, Mulder AH. Accumulation of p53 protein in normal, dysplastic. and neoplastic Barrett's oesophagus. J Pathol 1995;175:175-80.
31. Menke-Pluymers MBE. Risk factors for neoplastic progression in Barrett's mucosa. Eur J Surg Oncol 1996;22:311-6.
32. Streitz JM, Andrews CW, Ellis FH. Endoscopic surveillance of Barrett's oesophagus. Does it help? J Thorac Cardiovasc Surg 1993;105:383-8.
33. Achkar E, Carey W. The cost of surveillance for adenocarcinoma complicating Barrett's esophagus. Am J Gastroenterol 1988;83:291-4.
34. Provenzale D, Kemp JA, Arora S, Wong JB. A guide for surveillance of patients with Barrett's esophagus. Am J Gastroenterol 1994;89:670-80.
35. Van der burgh A, Dees J, Hop WCJ, van Blankenstein M. Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. Gut 1996;39:5-8.
36. Spechler SJ, Robbins AH, Bloomfield RH, Vincent ME, Heeren T, Doos WG, et al. Adenocarcinoma and Barrett's esophagus: an overrated risk? Gastroenterology 1984;87:927-33.
37. Sampliner RE, Garewal HS, Fennerty MB, Aickin M. Lack of impact of therapy on extent of Barrett's esophagus in 67 patients. Dig Dis Sci 1990;35:93-6.
38. Spechler SJ. Comparison of medical and surgical therapy tor complicated gastroesophageal reflux in veterans. N Engl J Med 1992;326:786-92.
39. Sagar PM, Ackroyd R, Hosie KB, Patterson JE, Stoddard CJ, Kingsnorth AN. Regression and progression of Barrett's oesophagus after antireflux surgery. Br J Surg 1995;82:806-10.
40. Ortiz A, Martinez de Haro LF, Parrilla P, Morales G, Molina J, Bermejo J, et al. Conservative treatment versus antireflux surgery in Barrett's oesophagus: long-term results of a prospective study. Br J Surg 1996;83:274-8.
41. Levine DS, Haggitt RC, Blount PL, Rabinovitch PS, Rusch VW, Reid BJ. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 1993;105:40-50.
42. Cameron AJ, Carpenter HA. Barrett's oesophagus, high grade dysplasia and early adenocarcinoma. Comparison of endoscopie biopsy and surgical pathology findings. Gut 1996;38 Suppl 1: T92.
43. Fleischer De Wang GQ, Dawsey SM, Tio TL, Kidwell JA, Zhoe B, et al. Endoscopic therapy for esophageal dysplasia and early esophageal cancer in Linxian, China. Implications for the United States. Gastrointest Endosc 1997;45:AB68.
44. Berenson MM, Johnson TD, Markowitz NR, Buchi KN, Samowitz WS. Restoration of squamous mucosa after ablation of Barrett's esophageal epithelium. Gastroenterology 1993;104: 1686-91.
45. Sampliner RE, Hixson LJ, Fennerty B, Garewal HS. Regression of Barrett's esophagus by laser ablation in an anacid environment. Dig Dis Sci 1993;38:365-8.
46. Van Hillegersberg R, Kort WJ, Wilson JHP. Current status of photodynamic therapy in oncology. Drugs 1994;48:510-27.
47. Overholt BF, Panjehpour M. Barrett's esophagus: photodynamic therapy for ablation of dysplasia, reduction of specialized mucosa, and treatment of superficial esophageal cancer. Gastrointest Endosc 1995;42:64-9.
48. Barr H, Shepherd NA, Dix A, Roberts DJH, Tan WC, Krasner N. Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX. Lancet 1996;348:584-5.
49. Overholt BF, Panjehpour M. Photodynamic therapy in Barrett's esophagus: reduction of specialized mucosa, ablation of dysplasia, and treatment of superficial esophageal cancer. Semin Surg Oncol 1995;11:372-6.
50. Laukka MA, Wang KK. Initial results using low-dose photodynamic therapy in the treatment of Barrett's esophagus. Gastrointest Endosc 1995;42:59-63.